TERN vs V
Terns Pharmaceuticals Inc (TERN) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
TERN currently screens at market cap $6.12B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the TERN and V stock pages for the full models.
Not investment advice.